Under the terms of its Charter, the Audit Committee meets at least six times a year, including periodic meetings held separately with management, the internal auditor and the independent auditor. The Audit Committee represents and assists the Pfizer Board with the oversight of the integrity of the Company's financial statements and internal controls, the Company´s compliance with legal and regulatory requirements, the independent auditor´s qualifications and independence, the performance of the Company´s internal audit function and the independent auditor.
The Pfizer Board of Directors has determined that all the members of the Audit Committee meet the financial literacy requirements of the New York Stock Exchange Listed Company rules relating to audit committees and that and that the following members of the Committee — Messrs. Cornwell, Echevarria, Narayen, Sanger and Ms. Nora Johnson — are "audit committee financial experts" for purposes of the Securities and Exchange Commission rules.
The Board of Directors also has determined that each of the members of the Audit Committee is "independent," as defined by the rules of the New York Stock Exchange.
|Board Member||Independent||Position||Financial Expertise|
|W. Don Cornwell||Yes||Member||Yes|
|Joseph J. Echevarria||Yes||Member||Yes|
|Suzanne Nora Johnson||Yes||Chair||Yes|
|Stephen W. Sanger||Yes||Member||Yes|
|James C. Smith||Yes||Member||Yes|